Company Social Responsibility

Open innovation is a strategy to improve R&D efficiency through collaborative research and development with various partners, such as external academia, government, and industry, rather than closed R&D, where all research and development is conducted within a company. It is becoming an essential survival strategy for pharmaceutical companies in the face of declining R&D productivity, increasing socioeconomic burden on healthcare expenditures, and complex and costly scientific and technological advances.

Through its Open Innovation strategy, Sanofi seeks to improve efficiency in the R&D phase of drug development, not only in basic research and drug discovery, but also by introducing translational medicine, which links basic research to clinical and product use, and by effectively validating the efficacy of therapeutics at the earliest stages of drug development.